 Clinical Oncology News | Bendamustine Impressive For Lymphomas Clinical Oncology News Chicago—The combination of bendamustine and rituximab (B-R) is superior to CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine and prednisone) plus rituximab (CHOP-R) for the first-line treatment of indolent lymphomas, according to results of a ... |
